Supplementary Figure S3 from Efficacy of Osimertinib in Patients with Lung Cancer Positive for Uncommon EGFR Exon 19 Deletion Mutations
Authors:
- Michael J. GrantMGMichael J. Grant
- Jacqueline V. AredoJAJacqueline V. Aredo
- Jacqueline H. StarrettJSJacqueline H. Starrett
- Paul StockhammerPSPaul Stockhammer
- Iris K. van Alderwerelt van RosenburghIRIris K. van Alderwerelt van Rosenburgh
- Anna WurtzAWAnna Wurtz
- Andrew J. Piper-ValilloAPAndrew J. Piper-Valillo
- Zofia PiotrowskaZPZofia Piotrowska
- Christina FalconCFChristina Falcon
- Helena A. YuHYHelena A. Yu
- Charu AggarwalCACharu Aggarwal
- Dylan ScholesDSDylan Scholes
Open Access
- 17 June 2026
- other
- Published by American Association for Cancer Research (AACR)